HomeTargets › TDP-43

TDP-43 (3 companies · 7 programs)

Companies with an active program directed at TDP-43.

Voyager Therapeutics, Inc. VYGR

  • TDP-43 targeting small molecule — Amyotrophic Lateral Sclerosis Preclinical
  • TDP-43 targeting small molecule — Frontotemporal Dementia Preclinical
  • selective small molecules — Amyotrophic Lateral Sclerosis Preclinical
  • selective small molecules — Frontotemporal Dementia Preclinical

ProMIS Neurosciences Inc. PMN

  • PMN267 — Amyotrophic Lateral Sclerosis Preclinical
  • PMN267 — Frontotemporal Dementia Preclinical

AC Immune SA ACIU

  • ACI-19626 — Frontotemporal Dementia Phase 1